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Abstract Metallothioneins (MT) are ubiquitous low molecular
weight metal binding proteins that may act as antioxidants. In
the present study, the cloned human MT-III coding region was
permanently transfected into GM00637 cells in order to
investigate the antioxidative effects of this brain-specific MT
isoform. GM00637/MT-III cells overexpressed MT-III mRNA
versus pcDNA3 plasmid-transfected control cells (GM00637).
When challenged with H2O2, the GM00637/MT-III cells
displayed significantly more resistance than the GM00637 cells,
as determined by cell cytotoxicity, lactate dehydrogenase
leakage, and lipid peroxidation. In addition, the GM00637/
MT-III cells were highly protected from the H2O2-induced
production of reactive oxygen species and DNA damage. These
results directly support the antioxidative role of MT-III, and
demonstrate MT-III can scavenge free oxygen radicals and
protect cells from oxidative stress. / 2002 Published by Else-
vier Science B.V. on behalf of the Federation of European Bio-
chemical Societies.
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1. Introduction
Oxygen-containing free radicals are considered to be in-
volved in many important biological reactions. Several harm-
ful reactions such as DNA degradation, membrane peroxida-
tion and the destruction of endothelial cells have been
attributed to oxygen-derived free radicals [1]. DNA damage
by oxygen free radical species can initiate carcinogenesis or
feature in the pathogenesis of neurodegenerative diseases [2].
Moreover, speci¢c cellular enzymatic defense mechanisms,
mediated by superoxide dismutase, glutathione peroxidase
and catalase, have been suggested to protect from oxygen
free radical species [3]. It has also been suggested that sulf-
hydryl-containing agents help to protect against radical-in-
duced damage [4].
Metallothioneins (MTs) are low molecular weight (9 7
kDa), cysteine-rich metal binding proteins [5]. In mammali-
ans, four members of the MT family have been identi¢ed [5,6].
MT-I/II are expressed in virtually all tissues, whereas MT-III
and MT-IV are localized mainly in the central nervous system
and the strati¢ed squamous epithelia, respectively. MTs may
be involved in the detoxi¢cation of potentially toxic heavy
metal ions and in the homeostasis of essential trace metals
[5,6]. However, growing interest has been focused on a role
of MTs as antioxidants because of their high thiol content,
which is exclusively involved in the formation of diamagnetic
metal^thiolate clusters, and of removing metal ions such as
copper and iron, which may prevent Fenton reaction [5,6].
Several studies have suggested that MT-I/II could have sig-
ni¢cant antioxidant capacity, and it has been suggested that
MT-I/II provide cellular protection against various oxidative
stress-induced cytotoxic injuries [5^9]. Furthermore, reports
on transgenic mice that overexpress MT-I/II and MT-I/II
knockout mice support such roles [10,11].
Recently, more evidence points towards the neuroprotective
role of MT-III, the brain-speci¢c member of the MT family.
MT-III was found at lower levels in Alzheimer’s disease
brains [12,13], and it has been proposed that MTs in the brain
can protect neuronal cells from the cytotoxicity of reactive
oxygen species (ROS) [14,15]. In addition, it has recently
been shown that mice de¢cient in MT-III are more susceptible
to seizures induced by kainic acid and that they exhibit greater
neuronal injury than normal mice [16]. These results suggest
that MT-III could have a neuroprotective role; however, the
mechanisms underlying such a protective role are unknown.
Moreover, MT’s proposed protective role as a free radical
scavenger may be of relevance in brain neurological diseases.
Therefore, MT-III, which is a unique protein, warrants fur-
ther study to further de¢ne its antioxidant nature and its in-
volvement in neuroprotection. The present study was under-
taken to determine whether brain-speci¢c MT-III, as a
neuroprotective agent, can protect from oxidative stress. For
this purpose, we developed a stable human MT-III-overex-
pressing cell line, GM00637/MT-III, which shows reduced cy-
totoxic and nuclear DNA oxidative damage when induced by
H2O2.
2. Materials and methods
2.1. Materials
Chemicals and cell culture materials were obtained from the follow-
ing sources: H2O2, Earle’s minimum essential medium (EMEM),
trypsin, G418, fetal bovine serum, and penicillin^streptomycin solu-
tion from Life Technologies; and dichlorodihydro£uorescein diacetate
from Molecular Probes. Other chemicals were of the highest commer-
cial grade available.
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2.2. Cell culture
The human ¢broblast GM00637 cell line was purchased from the
Coriell Institute for Medical Research and maintained in EMEM
supplemented with 10% fetal bovine serum, 2 mM L-glutamine,
100 U/ml penicillin, and 100 Wg/ml streptomycin at 37‡C in a 5%
CO2 humidi¢ed incubator.
2.3. Overexpression of MT-III
The human MT-III coding region was ampli¢ed from human cere-
bral cortical cDNA (Clontech, USA) by PCR. A sense primer includ-
ing the EcoRI restriction site (5P-AGCAGAATTCATGGACCCTGA-
GACCTGCCCCTGC-3P) and a reverse primer with the NotI
restriction site (5P-GCC GCGGCCGCTCACTGGCAGCAGCTG-
CACTTCTC-3P) were designed to amplify MT-III cDNA [17]. A sin-
gle PCR product was inserted in pcDNA3 plasmid (Invitrogen) and
sequenced by the dideoxynucleotide chain termination procedure.
Cells transfected with this plasmid are referred to as GM00637/MT-
III. Cells were transfected with the pcDNA3/MT-III plasmid or
pcDNA3 plasmid using a gene pulser transfection apparatus (Bio-
Rad). Forty-eight hours after transfection, the cells were incubated
with complete medium containing 400 Wg/ml of G418 for 5 weeks.
Cell clones resistant to G418 were isolated and analyzed.
2.4. MT-III mRNA measurement by RT-PCR
RNA was extracted using a total RNA separator kit, treated with
DNase I and reverse transcribed into cDNA before PCR was per-
formed, as previously described [18]. The sense and reverse primers
described above without restriction sites were used to amplify human
MT-III cDNA. RT-PCR of human MT-III mRNA was performed as
previously described [18].
2.5. Cell cytotoxicity
Cell cytotoxicity was assessed using a 3-[4,5-dimethylthiazol-2-yl]-
2,5-diphenyltetrazolium bromide (MTT)-based colorimetric assay kit
and a lactate dehydrogenase (LDH) assay kit (Roche), according to
the manufacturer’s instructions.
2.6. Lipid peroxidation
Lipid peroxidation in cells was determined using the thiobarbituric
acid-reactive substances (TBARS) reaction with malondialdehyde and
related compounds as previously described [19]. Lipid peroxidation
was expressed as TBARS nmol/mg protein.
2.7. Intracellular production of ROS
The £uorescent probe dichlorodihydro£uorescein diacetate was
used to monitor the intracellular generation of ROS by H2O2 [20].
2.8. Comet assay
Oxidative DNA damage was evaluated using the Comet assay.
Culture medium was aspirated from the cell monolayer and cells
were then exposed to di¡erent concentrations of H2O2 in phos-
phate-bu¡ered saline (PBS) for 5 min on ice. Following oxidant ex-
posure, cells were washed twice with ice-cold PBS. The cells were then
detached from the culture dishes and processed for the Comet assay
as previously described [21]. To quantitate the Comet assay, ethidium
bromide-stained nucleoids were examined under a Nikon £uorescence
microscope using Image-Pro 4.5 software (Media Cybernetics). One
hundred comets per slide were visually scored according to the
amount of DNA present in the tail. Under these conditions the tail
moment Tm= [(£uorescence intensity of the tail)/(£uorescence inten-
sity of the head)Utail length] re£ected DNA damage.
2.9. Statistical analyses
All experiments were repeated at least three times. Student’s t-test
was used to assess the statistical signi¢cance of di¡erences. A con¢-
dence level of 6 0.05 was considered signi¢cant.
3. Results
3.1. Metallothionein overexpression
Clones of GM00637 cells permanently expressing the
human MT-III coding region were obtained, and con¢rmed
by RT-PCR. Fig. 1 shows the results of a representative
clone. PCR ampli¢cation of the pcDNA3 plasmid containing
the MT-III coding region and RT-PCR ampli¢cation of
GM00637/MT-III cells yielded a single band of approximately
207 bp (lanes 3 and 4). No ampli¢cation was observed in
samples of GM00637/pcDNA3 (GM00637) cells (lanes 1 and
2). GM00637 and GM00637/MT-III cell growths were similar
(data not shown).
3.2. Cell cytotoxicity
Sensitivity of GM00637 and GM00637/MT-III cells to
H2O2-mediated cytotoxicity was quanti¢ed by the MTT as-
say. The overexpression of MT-III was associated with resis-
tance to H2O2 (Fig. 2A). The LC50 of GM00637/MT-III cell
to H2O2 was two- to three-fold greater than that of GM00637
cells. To more precisely quantify the di¡erent resistances of
the transfected cells to H2O2, we performed LDH assays, and
it was found that consistent with the MTT results GM00637/
MT-III cells withstood higher H2O2 doses than GM00637
cells (Fig. 2B). These results show that GM00637/MT-III cells
were less sensitive to the cytotoxic e¡ects of H2O2 than
GM00637 cells.
3.3. Levels of lipid peroxidation
TBARS were used to determine the antioxidant properties
of MT-III against H2O2-induced lipid peroxidation. No sig-
ni¢cant di¡erences in the basal lipid peroxidation levels were
found in these cells. In the GM00637 cells, lipid peroxidation
levels were found to gradually increase with time, whereas
lipid peroxidation levels in GM00637/MT-III cells increased
3 h after exposure to H2O2 (Fig. 2C). Moreover, lipid peroxi-
dation levels in the GM00637 cells were signi¢cantly higher
than those of the GM00637/MT-III cells at 2, 3 and 6 h.
Accordingly, MT-III accumulation in GM00637/MT-III cells
might increase resistance to oxidative stress.
3.4. Intracellular ROS production
Believing that di¡erences in intracellular MT-III content
a¡ect defense against oxidative stress, we further evaluated
the antioxidative properties of MT-III against H2O2. Intra-
cellular ROS production was assessed by monitoring dichlo-
rodihydro£uorescein (DCF) £uorescence. Prior to H2O2 addi-
tion, no di¡erence was seen between the DCF signals of
GM00637 and GM00637/MT-III. Rapid increases in intracel-
lular oxidant levels were noted in both cell types after H2O2
treatment, as assessed by increased DCF £uorescence, but the
oxidant burden after H2O2 exposure was greater in the
GM00637 cells (Fig. 2D). These results demonstrate that the
Fig. 1. Expression of human MT-III mRNA in stably transfected
GM00637/MT-III cells. The cells were lysed and total RNA was
prepared for RT-PCR analysis of gene expression. The PCR ampli-
¢cation products were electrophoresed in 2.5% agarose gel and
stained with ethidium bromide. One of three representative experi-
ments is shown. Lane M, 100 bp DNA ladder; lanes 1 and 2,
GM00637 cells; lanes 3 and 4, GM00637/MT-III cells.
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Fig. 2. The cells were treated with di¡erent concentrations of H2O2 for 3 h. Medium containing H2O2 was replaced with fresh medium without
H2O2, and cellular cytotoxicity was measured using a MTT-based colorimetric assay kit (A) and LDH activity measured using a LDH kit (B).
The cells were treated with 100 WM of H2O2 for 6 h and the extent of lipid peroxidation in the cells was determined by the TBARS reaction
(C). The cells were treated with 10 WM of dichlorodihydro£uorescein diacetate for 10 min and the medium was replaced by fresh medium con-
taining di¡erent concentrations of H2O2. After 15 min of treatment, intracellular ROS were measured by monitoring £uorescence increases (D).
The cells were treated with di¡erent concentrations of H2O2 for 5 min and oxidative DNA damage was evaluated using the Comet assay (E).
Each value represents the meanQS.D. of three independent experiments, performed in triplicate. *P6 0.05, signi¢cantly di¡erent from the
GM00637 cells.
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GM00637/MT-III cells had signi¢cantly higher antioxidant
activity than the GM00637 cells.
3.5. Oxidative DNA damage
The Comet assay was used to assess the e¡ects of MT-III
overexpression on oxidative DNA damage. The Comet assay
detects single- and double-stranded DNA breaks in naked
supercoiled DNA. Strand breaks cause supercoiled DNA to
relax, allowing loops of DNA to migrate toward the anode
upon electrophoresis, forming a ‘comet tail’. H2O2 (50 WM)
treatment increased three-fold the tail moments in GM00637
cells versus GM00637/MT-III cells, indicating a three-fold in-
crease in oxidative DNA damage (Fig. 2E).
4. Discussion
Oxidative stress is the result of an imbalance between the
production of ROS and the ability of the cellular antioxidant
defense systems. Cells have developed elaborate networks to
deal with potentially damaging radicals, and these include
enzymatic and non-enzymatic antioxidative systems. There is
increasing evidence that MTs can function as e¡ective antiox-
idants [5,6]. Therefore, we were interested to determine the
e¡ect of MT-III on oxidative stress in cells that constitutively
express MT-III. Thus, we cloned the coding region of human
MT-III and permanently transfected it into GM00637 cells.
RT-PCR results demonstrated the speci¢c expression of hu-
man MT-III mRNA in GM00637/MT-III cells ; however, no
transcript was found in reverse transcribed RNA samples of
pcDNA3 plasmid transfected GM00637 cells (Fig. 1).
H2O2 is particularly attractive as a model oxidant because
its cellular actions and its fate have been well studied [22].
H2O2 readily crosses the cellular membranes, and gives rise
to the highly reactive hydroxyl radicals, which have the ability
to react with macromolecules, including DNA, proteins, and
lipids, and to ultimately damage a cell. Lipid peroxidation is
considered to be an indirect measure of ROS generation. Pre-
vious studies have shown that cells overexpressing mouse MT-
I were resistant to tert-butyl hydroperoxide and prevented
lipid peroxidation by scavenging peroxyl radicals [10]. The
present study demonstrates a lower production of TBARS
in GM00637/MT-III cells than in GM00637 cells treated
with H2O2, and shows that overexpressed MT-III inhibits
H2O2-induced lipid peroxidation in GM00637/MT-III cells
(Fig. 2C). Despite the obvious di¡erences in TBARS, malon-
dialdehyde generated from non-lipid sources and other endog-
enous aldehydes can interfere with the TBARS assay. There-
fore, we determined DCF £uorescent changes after H2O2
treatment as an additional sensitive means of detecting intra-
cellular ROS. It was observed that the levels of ROS in
GM00637/MT-III cells were lower than in GM00637 cells
after H2O2 exposure (Fig. 2D). Taken together, these results
suggest a protective and an antioxidant role for MT-III in
cells versus free radical toxicity.
DNA damage and its subsequent repair were assessed by
the Comet assay (i.e. single-cell gel electrophoresis), a proce-
dure that detects DNA strand breaks in individual cells result-
ing from events such as direct scission of the DNA backbone
by free radical attack. As shown in Fig. 2E, H2O2 exposure
induced a higher level of DNA damage in GM00637 cells than
in GM00637/MT-III cells. These results suggest that the re-
duction in the DNA damage in£icted by H2O2 in GM00637/
MT-III cells is more likely to be related to elevations in MT-
III, which is able to react with and detoxify ROS directly.
MTs can be found in the cytoplasm and/or the nucleus and
their subcellular distribution may be critical for determining
their antioxidizing function [23]. The nuclear localization of
MT-I/II in cells has been shown and is reported to be of
importance in protecting DNA from oxidant-induced damage
[8]. The present study shows that GM00637/MT-III cells are
resistant to the cytotoxic (Fig. 2A^C) and DNA-damaging
(Fig. 2E) e¡ects of H2O2. Although we did not determine
the cellular distribution of MT-III expression in the cell after
gene transfer, we deduce that MT-III is present within both
the nucleus and the cytoplasm from the protective e¡ect
shown by GM00637/MT-III cells against the cytotoxic e¡ect
and the DNA strand breakage caused by H2O2.
The mechanism of the antioxidant e¡ects of the MTs re-
mains unclear; however, several lines of evidence support the
hypothesis that the increased expression of MTs provides pro-
tection against ROS [10,24]. It is suggested that MT-I/II can
function as antioxidants by increasing zinc and copper levels
in cells, which may activate antioxidant enzymes such as
superoxide dismutase [25]. Since MTs have a high cysteine
content, they can freely exchange metals with electrophiles,
and thus MTs function as antioxidants. Indeed, metal-free
MTs (thioneins) can then bind redox-active metals such as
Fe or Cu, and prevent Fenton reactions, or react directly
with H2O2 or hydroxyl radicals, and thus scavenge ROS be-
fore they can react with DNA. It has also been demonstrated
that the in vitro oxidation of MT-I/II cysteines induces metal
release [26], and that H2O2 can react directly with MT-I/II
sulfhydryl groups [27]. Furthermore, in an in vitro study, the
e⁄ciency of the protective e¡ect of MT-I/II against DNA
degradation from oxidative damage was much higher than
that of reduced glutathione [9]. The primary mode of free
radical attack of MT-I/II could be via its sulfhydryl groups,
although the detailed modes of action of MT-I/II, as an anti-
oxidant, are not known. In the present study, when
GM00637/MT-III cells were cultured in the presence of
H2O2, MT-III was expressed at a high level in the cells,
thus a¡ording strong protection against oxidative stress. It
is plausible that MT-III protects cells by sharing the mecha-
nisms described above for MT-I/II. Moreover, the MT-III
sequence can be aligned with those of MT-I/II so that the
position of all 20 constituent cysteine residues is completely
conserved [5,6].
Oxidative stress can damage both cells and tissues by gen-
erating free radicals. In the brain, oxygen free radicals are
constantly produced and these can damage brain cells. There
are several reports that MTs are associated with certain neu-
rological diseases such as Alzheimer’s disease and Parkinson’s
disease [12,28]. Moreover, it has been shown that 1-methyl-4-
phenyl-1,2,3,6-tetrahydropyridine, a neurotoxic agent that can
cause Parkinson’s disease, can generate free radicals and also
induce MTs [28]. MT-III has many possible roles in brain
neurological disease, for instance, MT-III is depleted in the
cortical regions of individuals with Alzheimer’s disease [12,13]
and MT-III regulation has been studied in several animal
models of brain damage [14,15]. Alterations in the expression,
content, or function of MT-III could, therefore, be involved in
some neurodegenerative situations and changes in the levels of
MTs may be important in the pathology of several neurolog-
ical diseases. The results reported here support this hypothesis
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and suggest that the antioxidative role of MT-III underlies its
neuroprotective e¡ect. Further study is required to fully
understand the exact role of MT-III in brain function, and
the antioxidative characteristics of MT-III required to coun-
teract the e¡ect of free radicals. However, the present study
provides, for the ¢rst time, evidence that MT-III can protect
cells from the oxidative damage caused by H2O2, and dem-
onstrates an antioxidant role for MT-III in mammalian cells.
This ¢nding further extends our understanding of the obvious
neuroprotective implications of brain speci¢c MT-III.
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